BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2915 related articles for article (PubMed ID: 19732719)

  • 1. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.
    Fridlender ZG; Sun J; Kim S; Kapoor V; Cheng G; Ling L; Worthen GS; Albelda SM
    Cancer Cell; 2009 Sep; 16(3):183-94. PubMed ID: 19732719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy.
    Kim S; Buchlis G; Fridlender ZG; Sun J; Kapoor V; Cheng G; Haas A; Cheung HK; Zhang X; Corbley M; Kaiser LR; Ling L; Albelda SM
    Cancer Res; 2008 Dec; 68(24):10247-56. PubMed ID: 19074893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity.
    Suzuki E; Kapoor V; Cheung HK; Ling LE; DeLong PA; Kaiser LR; Albelda SM
    Clin Cancer Res; 2004 Sep; 10(17):5907-18. PubMed ID: 15355924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Lapachone promotes the recruitment and polarization of tumor-associated neutrophils (TANs) toward an antitumor (N1) phenotype in NQO1-positive cancers.
    Tumbath S; Jiang L; Li X; Zhang T; Zahid KR; Zhao Y; Zhou H; Yin Z; Lu T; Jiang S; Chen Y; Chen X; Fu YX; Huang X
    Oncoimmunology; 2024; 13(1):2363000. PubMed ID: 38846085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.
    Zhang Q; Yang X; Pins M; Javonovic B; Kuzel T; Kim SJ; Parijs LV; Greenberg NM; Liu V; Guo Y; Lee C
    Cancer Res; 2005 Mar; 65(5):1761-9. PubMed ID: 15753372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression.
    Mishalian I; Bayuh R; Levy L; Zolotarov L; Michaeli J; Fridlender ZG
    Cancer Immunol Immunother; 2013 Nov; 62(11):1745-56. PubMed ID: 24092389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of transforming growth factor-{beta} signaling in tumor-reactive CD8(+) T cells activates the antitumor immune response cycle.
    Zhang Q; Yang XJ; Kundu SD; Pins M; Javonovic B; Meyer R; Kim SJ; Greenberg NM; Kuzel T; Meagher R; Guo Y; Lee C
    Mol Cancer Ther; 2006 Jul; 5(7):1733-43. PubMed ID: 16891459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells.
    Jarnicki AG; Lysaght J; Todryk S; Mills KH
    J Immunol; 2006 Jul; 177(2):896-904. PubMed ID: 16818744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid cancers.
    Wallace A; Kapoor V; Sun J; Mrass P; Weninger W; Heitjan DF; June C; Kaiser LR; Ling LE; Albelda SM
    Clin Cancer Res; 2008 Jun; 14(12):3966-74. PubMed ID: 18559619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual TGF-β and PD-1 blockade synergistically enhances MAGE-A3-specific CD8
    Chen X; Wang L; Li P; Song M; Qin G; Gao Q; Zhang Z; Yue D; Wang D; Nan S; Qi Y; Li F; Yang L; Huang L; Zhang M; Zhang B; Gao Y; Zhang Y
    Int J Cancer; 2018 Nov; 143(10):2561-2574. PubMed ID: 29981155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells.
    Fridlender ZG; Kapoor V; Buchlis G; Cheng G; Sun J; Wang LC; Singhal S; Snyder LA; Albelda SM
    Am J Respir Cell Mol Biol; 2011 Feb; 44(2):230-7. PubMed ID: 20395632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells.
    Zhang Q; Jang TL; Yang X; Park I; Meyer RE; Kundu S; Pins M; Javonovic B; Kuzel T; Kim SJ; Van Parijs L; Smith N; Wong L; Greenberg NM; Guo Y; Lee C
    Prostate; 2006 Feb; 66(3):235-47. PubMed ID: 16173028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gr-1+CD11b+ cells are responsible for tumor promoting effect of TGF-β in breast cancer progression.
    Li Z; Pang Y; Gara SK; Achyut BR; Heger C; Goldsmith PK; Lonning S; Yang L
    Int J Cancer; 2012 Dec; 131(11):2584-95. PubMed ID: 22487809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells.
    Chang LY; Lin YC; Mahalingam J; Huang CT; Chen TW; Kang CW; Peng HM; Chu YY; Chiang JM; Dutta A; Day YJ; Chen TC; Yeh CT; Lin CY
    Cancer Res; 2012 Mar; 72(5):1092-102. PubMed ID: 22282655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
    Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J
    Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells.
    Gorelik L; Flavell RA
    Nat Med; 2001 Oct; 7(10):1118-22. PubMed ID: 11590434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17--a new mechanism of impaired antitumor immunity.
    Mishalian I; Bayuh R; Eruslanov E; Michaeli J; Levy L; Zolotarov L; Singhal S; Albelda SM; Granot Z; Fridlender ZG
    Int J Cancer; 2014 Sep; 135(5):1178-86. PubMed ID: 24501019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma.
    Chung JY; Tang PC; Chan MK; Xue VW; Huang XR; Ng CS; Zhang D; Leung KT; Wong CK; Lee TL; Lam EW; Nikolic-Paterson DJ; To KF; Lan HY; Tang PM
    Nat Commun; 2023 Mar; 14(1):1794. PubMed ID: 37002229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.
    Jassar AS; Suzuki E; Kapoor V; Sun J; Silverberg MB; Cheung L; Burdick MD; Strieter RM; Ching LM; Kaiser LR; Albelda SM
    Cancer Res; 2005 Dec; 65(24):11752-61. PubMed ID: 16357188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.
    Rich S; Seelig M; Lee HM; Lin J
    J Immunol; 1995 Jul; 155(2):609-18. PubMed ID: 7608539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 146.